Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiency disorders: a prospective single center studyAmir Ali Hamidieh, Ardeshir Ghavamzadeh, Maryam Behfar et al.|Bone Marrow Transplantation|2015Cited by 19
Long-Term Safety of Short-Term Administration of Filgrastim (rhG-CSF) and Leukophresis Procedure in Healthy Children: Application of Peripheral Blood Stem Cell Collection in Pediatric DonorsMaryam Behfar, Amir Ali Hamidieh, Sara Faghihi‐Kashani et al.|Transplantation and Cellular Therapy|2017Cited by 16
The Safety of Granulocyte Colony Stimulating Factor (G-CSF) Administration in Pediatric Donors before Peripheral Hematopoietic Stem Cell DonationAmir Ali Hamidieh, Ardeshir Ghavamzadeh, Maryam Behfar et al.|Transplantation and Cellular Therapy|2015Cited by 1
Leukocyte Adhesion Deficiency Type I: The Outcome of Reduced-Intensity Conditioning Hematopoietic Stem Cell TransplantationAmir Ali Hamidieh, Ardeshir Ghavamzadeh, Zahra Pourpak et al.|Transplantation and Cellular Therapy|2015Cited by 1
National Consensus Guideline on Diagnosis and Management of Predominantly Antibody DeficienciesReza Yazdani, Samaneh Abdolahzade, Parisa Ashournia et al.|Immunology and Genetics Journal|2025Cited by 1